Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Austin, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Molecular Templates, Inc. has filed 1,223 SEC EDGAR filings since 27 Aug 2002

SEC filing history

Showing 651-675 of 864 matching filings.

Per page
25
Current page
27
4

SELICK FORM 4

Filing date
25 Mar 2013
Reporting date
13 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FERNANDES FORM 4

Filing date
25 Mar 2013
Reporting date
13 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32979

CURRENT REPORT

Filing date
15 Mar 2013
Reporting date
13 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-187107

FORM S-8

Filing date
07 Mar 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32979

FORM 8-K

Filing date
07 Mar 2013
Reporting date
07 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81377

SC 13G/A filing

Filing date
14 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81377

SC 13G/A

Filing date
14 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
5

5 filing

Filing date
13 Feb 2013
Reporting date
31 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
5

5 filing

Filing date
13 Feb 2013
Reporting date
31 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
5

5 filing

Filing date
13 Feb 2013
Reporting date
31 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81377

SCHEDULE 13G/A

Filing date
13 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81377

SC 13G/A filing

Filing date
12 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81377

SC 13G/A

Filing date
08 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81377

SC 13G/A

Filing date
04 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-81377

THRESHOLD PHARMACEUTICALS INC. SC 13G

Filing date
01 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32979

FORM 8-K

Filing date
25 Jan 2013
Reporting date
25 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-153475

424B3 filing

Filing date
11 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32979

CURRENT REPORT

Filing date
15 Nov 2012
Reporting date
15 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
07 Nov 2012
Reporting date
01 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
07 Nov 2012
Reporting date
01 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32979

8-K

Filing date
02 Nov 2012
Reporting date
02 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32979

FORM 8-K

Filing date
16 Oct 2012
Reporting date
16 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PARKER FORM 4

Filing date
15 Oct 2012
Reporting date
11 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .